| Product NDC: | 49884-701 |
| Proprietary Name: | Clomiphene Citrate |
| Non Proprietary Name: | Clomiphene Citrate |
| Active Ingredient(s): | 50 mg/1 & nbsp; Clomiphene Citrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-701 |
| Labeler Name: | Par Pharmaceutical Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075528 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19990830 |
| Package NDC: | 49884-701-55 |
| Package Description: | 3 BLISTER PACK in 1 CARTON (49884-701-55) > 10 TABLET in 1 BLISTER PACK |
| NDC Code | 49884-701-55 |
| Proprietary Name | Clomiphene Citrate |
| Package Description | 3 BLISTER PACK in 1 CARTON (49884-701-55) > 10 TABLET in 1 BLISTER PACK |
| Product NDC | 49884-701 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Clomiphene Citrate |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19990830 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Inc |
| Substance Name | CLOMIPHENE CITRATE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |